Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by carduon Dec 21, 2011 1:01pm
372 Views
Post# 19342342

RE: RE: RE: Food for thought!

RE: RE: RE: Food for thought!
I'm certain that the option grants issued below at the strike price of $3.50+ is purely coincidental to the collapse of the SP for the shareholders. I am in awe that the CEO of a company whose SP has dropped 50% in one year can be rewarded for such a dismal record.


Dec 16/11 Dec 14/11 Schultz, Robert Direct Ownership Options 50 - Grant of options 70,000
Dec 16/11 Dec 14/11 Stewart, Fred Direct Ownership Options 50 - Grant of options 55,000
Dec 16/11 Dec 14/11 Thompson, Bradley Direct Ownership Options 50 - Grant of options 240,000
Dec 16/11 Dec 14/11 van Amersfoort, Ger Direct Ownership Options 50 - Grant of options 30,000
Dec 16/11 Dec 14/11 Lievonen, John Mark Direct Ownership Options 50 - Grant of options 35,000
Dec 16/11 Dec 14/11 Gill, George Direct Ownership Options 50 - Grant of options 35,000
Dec 16/11 Dec 14/11 Dinning, James Francis Direct Ownership Options 50 - Grant of options 35,000
Dec 16/11 Dec 14/11 Levy, Edwin Direct Ownership Options 50 - Grant of options 30,000
Dec 16/11 Dec 14/11 Dillahunty, Mary Ann Direct Ownership Options 50 - Grant of options 45,000
Dec 16/11 Dec 14/11 Coffey, Matthew Direct Ownership Options 50 - Grant of


Bullboard Posts